TDOC icon

Teladoc Health

7.53 USD
-0.67
8.17%
At close Jul 29, 4:00 PM EDT
Pre-market
7.88
+0.35
4.65%
1 day
-8.17%
5 days
-12.44%
1 month
-13.55%
3 months
2.73%
6 months
-27.25%
Year to date
-20.90%
1 year
-21.32%
5 years
-96.55%
10 years
-76.15%
 

About: Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.

Employees: 5,500

0
Funds holding %
of 7,323 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

13% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 52

12% more repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 106

0% less funds holding

Funds holding: 374 [Q4 2024] → 373 (-1) [Q1 2025]

2% less call options, than puts

Call options by funds: $54.4M | Put options by funds: $55.3M

1.75% less ownership

Funds ownership: 73.59% [Q4 2024] → 71.84% (-1.75%) [Q1 2025]

14% less capital invested

Capital invested by funds: $1.15B [Q4 2024] → $994M (-$159M) [Q1 2025]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$7
7%
downside
Avg. target
$9
20%
upside
High target
$12
59%
upside

8 analyst ratings

positive
25%
neutral
75%
negative
0%
Mizuho
Steven Valiquette
33%upside
$10
Neutral
Initiated
25 Jul 2025
Evercore ISI Group
Elizabeth Anderson
6%upside
$8
In-Line
Maintained
9 Jul 2025
B of A Securities
Allen Lutz
7%downside
$7
Neutral
Maintained
28 May 2025
Truist Securities
Jailendra Singh
20%upside
$9
Hold
Maintained
27 May 2025
Wells Fargo
Stan Berenshteyn
6%upside
$8
Equal-Weight
Maintained
8 May 2025

Financial journalist opinion

Based on 11 articles about TDOC published over the past 30 days

Neutral
Seeking Alpha
9 hours ago
Teladoc Health, Inc. (TDOC) Q2 2025 Earnings Call Transcript
Teladoc Health, Inc. Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ET Company Participants Charles Divita - CEO & Director Mala Murthy - Chief Financial Officer Michael Minchak - Vice President of Investor Relations Conference Call Participants Sarah Elizabeth James - Cantor Fitzgerald & Co., Research Division Charles Rhyee - TD Cowen, Research Division Daniel R. Grosslight - Citigroup Inc., Research Division David Harrison Roman - Goldman Sachs Group, Inc., Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division Jailendra P.
Teladoc Health, Inc. (TDOC) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
9 hours ago
Teladoc (TDOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Teladoc (TDOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Neutral
Zacks Investment Research
9 hours ago
Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates
Teladoc (TDOC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.28 per share a year ago.
Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates
Neutral
PRNewsWire
19 hours ago
Wingspan Raises $24M Series B to Scale Embedded Contractor Management and Capture $1.4T Market
Series B led by Touring Capital will propel Wingspan's mission to make flexible work effortless; launch of Wingspan Embed brings comprehensive contractor management to HR platforms NEW YORK , July 29, 2025 /PRNewswire/ -- Wingspan , the first modern payroll platform purpose-built for contractor management, announced that it has raised $24 million in Series B funding led by Touring Capital, bringing its total capital raised to $54 million. Existing investors Andreessen Horowitz, Long Journey Ventures, Distributed Ventures, Company Ventures, and 186 Ventures also participated.
Wingspan Raises $24M Series B to Scale Embedded Contractor Management and Capture $1.4T Market
Positive
Zacks Investment Research
1 day ago
HIMS vs. TDOC: Which Direct-to-Consumer Health Stock Wins Now?
Hims & Hers and Teladoc Health are reshaping virtual care, but which has the edge in earnings growth and strategic expansion? Let's see.
HIMS vs. TDOC: Which Direct-to-Consumer Health Stock Wins Now?
Negative
Zacks Investment Research
1 week ago
Teladoc (TDOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Neutral
GlobeNewsWire
1 week ago
Teladoc Health to Announce Second Quarter 2025 Financial Results
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day.
Teladoc Health to Announce Second Quarter 2025 Financial Results
Neutral
GlobeNewsWire
2 weeks ago
Teladoc Health Launches Wellbound Employee Assistance Program (EAP)
New EAP supports mental health and well-being across a broad spectrum of needs—from everyday work-life challenges to complex mental health conditions.
Teladoc Health Launches Wellbound Employee Assistance Program (EAP)
Positive
Seeking Alpha
3 weeks ago
Teladoc Health: A Beaten-Down Bargain Worth A Second Look (Upgrade)
I've upgraded Teladoc to a tepid buy—not a full conviction call, but the numbers finally tilt in its favor. I believe the company's innovative platform positions it as a leader in digital healthcare, driving long-term value. 7x forward free cash flow is just too low to ignore, even with weak top-line growth.
Teladoc Health: A Beaten-Down Bargain Worth A Second Look (Upgrade)
Neutral
Zacks Investment Research
4 weeks ago
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Teladoc (TDOC) concluded the recent trading session at $8.58, signifying a -1.49% move from its prior day's close.
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Charts implemented using Lightweight Charts™